Philadelphia, PA, United States of America

Avinash Kaur

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Pennsylvania. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Avinash Kaur. Retrieved from https://idiyas.com/inventor/avinash-kaur-rz96zwwt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Avinash Kaur: Innovator in Medical Research

Introduction

Avinash Kaur is a notable inventor based in Philadelphia, PA. He has made significant contributions to the field of medical research, particularly in the treatment of genetic disorders. His work focuses on developing innovative solutions to address critical health challenges.

Latest Patents

Avinash Kaur holds a patent for "P38 map kinase inhibitors for treating Friedreich's ataxia." This invention provides p38 MAPK inhibitors that compensate for a frataxin deficiency or mutation. The methods outlined in the patent aim to treat Friedreich's ataxia, a debilitating genetic condition.

Career Highlights

Kaur is affiliated with the University of Pennsylvania, where he conducts his research. His work has garnered attention for its potential impact on patients suffering from rare genetic disorders. With a focus on innovative treatments, he continues to push the boundaries of medical science.

Collaborations

Some of his notable coworkers include Robert B. Wilson and Maria Grazia Cotticelli. Their collaborative efforts contribute to advancing research in the field of genetic therapies.

Conclusion

Avinash Kaur's contributions to medical research exemplify the importance of innovation in addressing complex health issues. His work on p38 MAPK inhibitors represents a significant step forward in the treatment of Friedreich's ataxia.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…